From blunt to precision: Engineering microbiome therapeutics against cancer.

Turning bacterial surfaces into oral vaccine couriers and microbial metabolism into controllable reactors demonstrates how microbiome therapeutics can be transformed into precision platforms for cancer immunotherapy.

• Why it matters: Current microbiome therapies often rely on selecting beneficial strains without precise control over their activity or location, limiting their effectiveness in cancer treatment. Advancing these approaches could enable targeted, measurable, and controllable interventions within the gut.
• What they did: Two recent papers in Cell Host & Microbe employed engineering strategies to convert bacterial surfaces into oral vaccine carriers and microbial metabolism into controllable reactors, emphasizing the importance of location, control, and output measurement.
• The result: These approaches show how the gut microbiome can be harnessed as a precise, controllable platform for cancer immunotherapy, potentially improving therapeutic efficacy and specificity.